Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest
Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest
Body unavailable. Use the original source.
Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.